Across TCGA pan-cancer cohorts, LINC00951 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of LINC00951’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where LINC00951 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC00951 is over-expressed in tumor, although a few such as HNSC and PRAD show the opposite, repressed pattern.

BRCA, HNSC, and KICH are the cancer types where LINC00951 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC00951 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	All	+0.106	.001	6	view →
HNSC	All	All	−0.145	.004	5	view →
KICH	All	All	+0.181	.029	2	view →
PRAD	All	All	−0.017	.025	2	view →
KIRP	All	All	−0.025	.036	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: LINC00951 RNA expression & survival · all LINC00951 data types